Michael S. Hofman
2003–2026 年に発表
- 188
- 論文数
- 22,707
- 被引用数
- 78
- h 指数
- 172
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine91%
- Biochemistry, Genetics and Molecular Biology3.7%
- Physics and Astronomy1.2%
- Engineering1%
- Computer Science1%
- Immunology and Microbiology0.6%
- その他1.5%
トピック
- Prostate Cancer Treatment and Research17.9%
- Radiopharmaceutical Chemistry and Applications13.3%
- Prostate Cancer Diagnosis and Treatment11.4%
- Medical Imaging Techniques and Applications4.6%
- Neuroendocrine Tumor Research Advances3.7%
- Radiomics and Machine Learning in Medical Imaging2.4%
- その他46.7%
共著者
- Rodney J. Hicks53
- Declan G. Murphy49
- Louise Emmett45
- Shahneen Sandhu39
- Arun Azad33
- Amir Iravani31
- James P Buteau31
- Grace Kong30
- Nathan Lawrentschuk28
- Scott Williams26
- Roslyn J. Francis25
- David A. Pattison21
- Ian D. Davis21
- Price Jackson21
- Shankar Siva21
- Anthony M. Joshua20
- Jérémie Calais20
- Wolfgang P. Fendler20
- Matthias Eiber19
- Ken Herrmann18
- Ramin Alipour17
- Thomas A. Hope17
- Tim Akhurst17
- Martin R. Stockler16
全論文
- Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
著者: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, Colin Tang, Ian Vela, Paul Thomas, Natalie Rutherford, Jarad Martin, Mark Frydenberg, Ramdave Shakher, Lih‐Ming Wong, Kim Taubman, Sze Ting Lee, Edward Hsiao, Paul Roach, Michelle Nottage, Ian Kirkwood, Dickon Hayne, Emma Link, Petra Marušić, A Matera, Alan Herschtal, Amir Iravani, Rodney J. Hicks, Scott Williams, Declan G. Murphy - The Lancet 2020 被引用: 1,962
- [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
著者: Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, Anthony M. Joshua, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Siobhan Ng, Roslyn J. Francis, Craig Gedye, Natalie Rutherford, Andrew Weickhardt, Andrew M. Scott, Sze-Ting Lee, Edmond M. Kwan, Arun Azad, Shakher Ramdave, Andrew Redfern, W A Macdonald, Alex Guminski, Edward Hsiao, Wei Chua, Peter Lin, Alison Y. Zhang, Margaret McJannett, Martin R. Stockler, John Violet, Scott Williams, Andrew Martin, Ian D. Davis, Arun Azad, Wei Chua, Ian D. Davis, Nattakorn Dhiantravan, Louise Emmett, Kate Ford, Michael S. Hofman, Roslyn J. Francis, Craig Gedye, Jeffrey C. Goh, Alex Guminski, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Siobhan Ng, David A. Pattison, Shakher Ramdave, Nisha Rana, Andrew Redfern, Natalie Rutherford, Shahneen Sandhu, Andrew M. Scott, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, John Violet, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang - The Lancet 2021 被引用: 1,082
- The Lancet Commission on prostate cancer: planning for the surge in cases
著者: Nicholas D. James, Ian F. Tannock, James N’Dow, Felix Y. Feng, Silke Gillessen, Syed Adnan Ali, Blanca Trujillo, Bissan Al‐Lazikani, Gerhardt Attard, Freddie Bray, Éva Compérat, Rosalind A. Eeles, Omolara Fatiregun, Emily Grist, Susan Halabi, Áine Haran, Daniel Herchenhorn, Michael S. Hofman, Mohamed Jalloh, Stacy Loeb, Archie Macnair, Brandon A. Mahal, Larissa Mendes, Masood Moghul, Caroline M. Moore, Alicia K. Morgans, Michael J. Morris, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, Anwar R. Padhani, Charles Parker, Hannah Rush, Mark Sculpher, Howard R. Soule, Matthew R. Sydes, Derya Tilki, Nina Tunariu, Paul Villanti, Liping Xie - The Lancet 2024 被引用: 643
- [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
著者: Michael S. Hofman, John Violet, Rodney J. Hicks, Justin Ferdinandus, Sue Ping Thang, Tim Akhurst, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Declan G. Murphy, Peter Eu, Price Jackson, Mark Scalzo, Scott Williams, Shahneen Sandhu - The Lancet Oncology 2018 被引用: 1,143
- Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes
著者: John Violet, Price Jackson, Justin Ferdinandus, Shahneen Sandhu, Tim Akhurst, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Sue Ping Thang, Peter Eu, Mark Scalzo, Declan G. Murphy, Scott Williams, Rodney J. Hicks, Michael S. Hofman - Journal of Nuclear Medicine 2018 被引用: 486
- Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
著者: Marlon Perera, Nathan Papa, Matthew J. Roberts, Michael B. Williams, Cristian Udovicich, Ian Vela, Daniel Christidis, Damien Bolton, Michael S. Hofman, Nathan Lawrentschuk, Declan G. Murphy - European Urology 2019 被引用: 952
- PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial
著者: James P Buteau, Andrew Martin, Louise Emmett, Amir Iravani, Shahneen Sandhu, Anthony M. Joshua, Roslyn J. Francis, Alison Y. Zhang, Andrew M. Scott, Sze-Ting Lee, Arun Azad, Margaret McJannett, Martin R. Stockler, Scott Williams, Ian D. Davis, Michael S. Hofman, Tim Akhurst, Ramin Alipour, Arun Azad, Patricia Banks, Alexis Beaulieu, James P Buteau, Wei Chua, Ian D. Davis, Nattakorn Dhiantravan, Louise Emmett, Kate Ford, Michael S. Hofman, Roslyn J. Francis, Craig Gedye, Jeffrey C. Goh, Alex Guminski, Anis Hamid, Mohammad B. Haskali, Rodney J. Hicks, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Grace Kong, Edmond M. Kwan, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Jeremy Lewin, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Kate Moodie, Declan G. Murphy, Siobhan Ng, David A. Pattison, Izabella Pokorski, Shakher Ramdave, Aravind S. Ravi Kumar, Andrew Redfern, Natalie Rutherford, Javad Saghebi, Shahneen Sandhu, Andrew M. Scott, Lavinia Spain, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, Sue Ping Thang, Ben Tran, Roslyn E. Wallace, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang, Sonia Yip, Alison Y. Zhang - The Lancet Oncology 2022 被引用: 266
- The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study
著者: Louise Emmett, James P Buteau, Nathan Papa, Daniel Moon, James Thompson, Matthew J. Roberts, Kris Rasiah, David A. Pattison, John Yaxley, Paul Thomas, Anthony Hutton, Shikha Agrawal, Amer Amin, Alexandar Blazevski, Venu Chalasani, Bao Ho, Andrew Nguyen, Victor Liu, Jonathan Lee, Gemma Sheehan‐Dare, Raji Kooner, Geoff Coughlin, Lyn Chan, Thomas W. Cusick, Benjamin Namdarian, Jada Kapoor, Omar Alghazo, Henry H. Woo, Nathan Lawrentschuk, Declan G. Murphy, Michael S. Hofman, Phillip D. Stricker - European Urology 2021 被引用: 418
- Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
著者: Clemens Kratochwil, Wolfgang P. Fendler, Matthias Eiber, Michael S. Hofman, Louise Emmett, Jérémie Calais, Joseph R. Osborne, Amir Iravani, Phillip J. Koo, Liza Lindenberg, Richard P. Baum, Murat Fani Bozkurt, Roberto C. Delgado Bolton, Samer Ezziddin, Flavio Forrer, Rodney J. Hicks, Thomas A. Hope, Levent Kabasakal, Mark Konijnenberg, Klaus Kopka, Michael Laßmann, Felix M. Mottaghy, Wim J.G. Oyen, Kambiz Rahbar, Heiko Schöder, Irene Virgolini, Lisa Bodei, Stefano Fanti, Uwe Haberkorn, Ken Hermann - European Journal of Nuclear Medicine and Molecular Imaging 2023 被引用: 255
- Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
著者: Robert Seifert, Louise Emmett, Steven P. Rowe, Ken Herrmann, Boris Hadaschik, Jérémie Calais, Frederik L. Giesel, Robert E. Reiter, Tobias Maurer, Matthias Heck, Andrei Gafita, Michael J. Morris, Stefano Fanti, Wolfgang Weber, Thomas A. Hope, Michael S. Hofman, Wolfgang P. Fendler, Matthias Eiber - European Urology 2023 被引用: 276
- Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
著者: Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, James P Buteau, Anthony M. Joshua, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Siobhan Ng, Roslyn J. Francis, Craig Gedye, Natalie Rutherford, Andrew Weickhardt, Andrew M. Scott, Sze-Ting Lee, Edmond M. Kwan, Arun Azad, Shakher Ramdave, Andrew Redfern, W A Macdonald, Alex Guminski, Edward Hsiao, Wei Chua, Peter Lin, Alison Yan Zhang, Martin R. Stockler, Scott Williams, Andrew Martin, Ian D. Davis, Tim Akhurst, Ramin Alipour, Dale L. Bailey, Patricia Banks, Alexis Beaulieu, Louise Campbell, Megan Crumbaker, Nattakorn Dhiantravan, Anis Hamid, Mohammad B. Haskali, Terry Hung, Grace Kong, Nick Lawrence, Jeremy Lewin, Michael McCarthy, Kate Moodie, Declan G. Murphy, Andrew Nguyen, David Pook, Aravind Ravi Kumar, Paul Roach, Peter Roselt, Javad Saghebi, Geoffrey Schembri, Lavinia Spain, Shalini Subramaniam, Sue Ping Thang, Paul Thomas, Ben Tran, Roslyn E. Wallace, Sonia Yip - The Lancet Oncology 2023 被引用: 199
- Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
著者: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind Mrabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157
- Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study
著者: Andrei Gafita, Jérémie Calais, Tristan Grogan, Boris Hadaschik, Hui Wang, Manuel Weber, Shahneen Sandhu, Clemens Kratochwil, Rouzbeh Esfandiari, Robert Tauber, Anna Zeldin, Hendrik Rathke, Wesley R. Armstrong, Andrew Robertson, Pan Thin, Calogero D’Alessandria, Matthew B. Rettig, Ebrahim S. Delpassand, Uwe Haberkorn, David Elashoff, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Wolfgang P. Fendler, Matthias Eiber - The Lancet Oncology 2021 被引用: 246
- E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
著者: Francesco Ceci, Daniela E. Oprea‐Lager, Louise Emmett, Judit A. Adam, Jamshed Bomanji, Johannes Czernin, Matthias Eiber, Uwe Haberkorn, Michael S. Hofman, Thomas A. Hope, Rakesh Kumar, Steven P. Rowe, Sarah Schwarzenboeck, Stefano Fanti, Ken Herrmann - European Journal of Nuclear Medicine and Molecular Imaging 2021 被引用: 359
- Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
著者: John Violet, Shahneen Sandhu, Amir Iravani, Justin Ferdinandus, Sue-Ping Thang, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, David A. Pattison, Alexis Beaulieu, Jennifer Mooi, Ben Tran, Christina Guo, Victor Kalff, Declan G. Murphy, Price Jackson, Peter Eu, Mark Scalzo, Scott Williams, Rodney J. Hicks, Michael S. Hofman - Journal of Nuclear Medicine 2019 被引用: 286
- Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis
著者: Kit Mun Chow, Wei Zheng So, Han Jie Lee, Alvin Lee, Dominic Wei Ting Yap, Yemisi Takwoingi, Kae Jack Tay, Jeffrey Tuan, Sue Ping Thang, Winnie Lam, John Chi–Hang Yuen, Nathan Lawrentschuk, Michael S. Hofman, Declan G. Murphy, Kenneth Chen - European Urology 2023 被引用: 176
- [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
著者: Louise Emmett, Shalini Subramaniam, Megan Crumbaker, Andrew Nguyen, Anthony M. Joshua, Andrew Weickhardt, Sze-Ting Lee, Siobhan Ng, Roslyn J. Francis, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Craig Gedye, Natalie Rutherford, Shahneen Sandhu, Aravind Ravi Kumar, David Pook, Shakher Ramdave, David Nadebaum, Mark Voskoboynik, Andrew Redfern, W A Macdonald, Laurence E. Krieger, Geoffrey Schembri, Wei Chua, Peter Lin, Lisa G. Horvath, Patricia Bastick, Patrick Butler, Alison Yan Zhang, Sonia Yip, Hayley Thomas, Ailsa Langford, Michael S. Hofman, Margaret McJannett, Andrew Martin, Martin R. Stockler, Ian D. Davis - The Lancet Oncology 2024 被引用: 155
- 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
著者: Jérémie Calais, Francesco Ceci, Matthias Eiber, Thomas A. Hope, Michael S. Hofman, Christoph Rischpler, Tore Bach‐Gansmo, Cristina Nanni, Bital Savir-Baruch, David Elashoff, Tristan Grogan, Magnus Dahlbom, Roger Slavik, J Gartmann, Kathleen Nguyen, Vincent Lok, Hossein Jadvar, Amar U. Kishan, Matthew B. Rettig, Robert E. Reiter, Wolfgang P. Fendler, Johannes Czernin - The Lancet Oncology 2019 被引用: 469
- Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
著者: Marlon Perera, Nathan Papa, Daniel Christidis, David Wetherell, Michael S. Hofman, Declan G. Murphy, Damien Bolton, Nathan Lawrentschuk - European Urology 2016 被引用: 1,002
- Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
著者: Price Jackson, Michael S. Hofman, Rodney J. Hicks, Mark Scalzo, John Violet - Journal of Nuclear Medicine 2019 被引用: 137
- Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
著者: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind Mrabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Urology 2022 被引用: 118
- Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer
著者: Wolfgang P. Fendler, Manuel Weber, Amir Iravani, Michael S. Hofman, Jérémie Calais, Johannes Czernin, Harun Ilhan, Fred Saad, Eric J. Small, Matthew R. Smith, Paola M. Perez, Thomas A. Hope, Isabel Rauscher, Anil Londhe, Angela Lopez‐Gitlitz, Shinta Cheng, Tobias Maurer, Ken Herrmann, Matthias Eiber, Boris Hadaschik - Clinical Cancer Research 2019 被引用: 267
- Radiotherapy and theranostics: a Lancet Oncology Commission
著者: May Abdel–Wahab, Francesco Giammarile, M. Carrara, Diana Páez, Hedvig Hricak, Nayyereh Ayati, Jing Jing Li, Malina Mueller, Ajay Aggarwal, Akram Al‐Ibraheem, Sondos A. Al-Khatib, Rifat Atun, Abubakar Bello, Daniel Berger, Roberto C. Delgado Bolton, John M. Buatti, Graeme Burt, Olivera Ciraj‐Bjelac, Lisbeth Cordero-Mendez, Manjit Dosanjh, Thomas Eichler, Elena Fidarova, Soehartati Gondhowiardjo, Mary Gospodarowicz, Surbhi Grover, Varsha Hande, Ekaterina Harsdorf-Enderndorf, Ken Herrmann, Michael S. Hofman, Ola Holmberg, David A. Jaffray, Peter Knoll, Jolanta Kunikowska, Jason S. Lewis, Yolande Lievens, Miriam Mikhail-Lette, Dennis A. Ostwald, Jatinder Palta, Platon Peristeris, Arthur Accioly Rosa, Soha Ahmed Salem, Marcos Augusto dos Santos, Mike Sathekge, Shyam Kishore Shrivastava, Egor Titovich, Jean-Luc Urbain, Verna Vanderpuye, Richard L. Wahl, Jennifer S. Yu, Mohamed S. Zaghloul, Hongcheng Zhu, Andrew M. Scott - The Lancet Oncology 2024 被引用: 120
- Using PSMA imaging for prognostication in localized and advanced prostate cancer
著者: Matthew J. Roberts, Tobias Maurer, Marlon Perera, Matthias Eiber, Thomas A. Hope, Piet Ost, Shankar Siva, Michael S. Hofman, Declan G. Murphy, Louise Emmett, Wolfgang P. Fendler - Nature Reviews Urology 2022 被引用: 83
